Accurate pre-operative localization of pathological parathyroid glands using 11C-methionine PET/CT

Contrast Media and Molecular Imaging

Volumn 3, Issue 4, 2008, Pages 157-163

  Tang, Bich Ngoc Thanh ^a,b   Moreno Reyes, Rodrigo ^a   Blocklet, Didier ^a   Corvilain, Bernard ^b   Cappello, Matteo ^b   Delpierre, Isabelle ^b   Devuyst, France ^b   Van Simaeys, Gaetan ^a   Goldman, Serge ^a  

^a UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

^b ERASME HOSPITAL   (Belgium)

Author keywords

11C methionine; Minimal access surgery; Pathological parathyroid glands; PET CT

Indexed keywords

METHIONINE C 11; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; PERTECHNETIC ACID TC 99M;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; FEMALE; GUIDED IMAGERY; HUMAN; IMAGE DISPLAY; MALE; PARATHYROID ADENOMA; PARATHYROID GLAND; PARATHYROID HYPERPLASIA; POSITRON EMISSION TOMOGRAPHY; PREOPERATIVE EVALUATION; PRIMARY HYPERPARATHYROIDISM; PRIORITY JOURNAL; SECONDARY HYPERPARATHYROIDISM; SENSITIVITY AND SPECIFICITY; THYROIDECTOMY; TREATMENT PLANNING;

ADULT; AGED; CARBON RADIOISOTOPES; HUMANS; METHIONINE; MIDDLE AGED; PARATHYROID GLANDS; POSITRON-EMISSION TOMOGRAPHY; PREOPERATIVE CARE; RADIOPHARMACEUTICALS; REPRODUCIBILITY OF RESULTS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 57649170732     PISSN: 15554309     EISSN: 15554317     Source Type: Journal    
DOI: 10.1002/cmmi.243     Document Type: Article

References (29)

1. Doppman JL, Dwyer A. Postoperative parathyroid high-frequency sonography: evaluation of persistent or recurrent hyperparathyroidism. Invest. Radiol. 1986; 21: 186-187.
2. Palazzo FF, Delbridge LW. Minimal-access/minimally invasive parathyroidectomy for primary hyperparathyroidism. Surg. Clin. N. Am. 2004; 84: 717-734.
3. Reeve TS, Babidge WJ, Parkyn RF, Edis AJ, Delbridge LW, Devitt PG, Maddern GJ. Minimally invasive surgery for primary hyperparathyroidism: systematic review. Arch. Surg. 2000; 135: 481-487.
4. Coakley AJ, Kettle AG, Wells CP, O'Doherty MJ, Collins RE. 99Tcm sestamibi - a new agent for parathyroid imaging. Nucl. Med. Commun. 1989; 10: 791-794.
5. Wei JP, Burke GJ, Mansberger AR Jr. Preoperative imaging of abnormal parathyroid glands in patients with hyperparathyroid disease using combination Tc-99m-pertechnetate and Tc-99m-sestamibi radionuclide scans. Ann. Surg. 1994; 219: 568-572; discussion 572-563.
6. Johnston LB, Carroll MJ, Britton KE, Lowe DG, Shand W, Besser GM, Grossman AB. The accuracy of parathyroid gland localization in primary hyperparathyroidism using sestamibi radionuclide imaging. J. Clin. Endocrinol. Metab. 1996; 81: 346-352.
7. Ishibashi M, Nishida H, Hiromatsu Y, Kojima K, Uchida M, Hayabuchi N. Localization of ectopic parathyroid glands using technetium-99m sestamibi imaging: comparison with magnetic resonance and computed tomographic imaging. Eur. J. Nucl. Med. 1997; 24: 197-201.
8. Caixas A, Berna L, Piera J, Rigla M, Matias-Guiu X, Farrerons J, Puig-Domingo M. Utility of 99mTc-sestamibi scintigraphy as a first-line imaging procedure in the preoperative evaluation of hyperparathyroidism. Clin. Endocrinol. (Oxf.) 1995; 43: 525-530.
9. Carlier T, Oudoux A, Mirallie E, Seret A, Daumy I, Leux C, Bodet-Milin C, Kraeber-Bodere F, Ansquer C. 99mTc-MIBI pinhole SPECT in primary hyperparathyroidism: comparison with conventional SPECT, planar scintigraphy and ultrasonography. Eur. J. Nucl. Med. Mol. Imag. 2008; 35: 637-643.
10. Wakamatsu H, Noguchi S, Yamashita H, Tamura S, Jinnouchi S, Nagamachi S, Futami S. Parathyroid scintigraphy with 99mTc-MIBI and 1231 subtraction: a comparison with magnetic resonance imaging and ultrasonography. Nucl. Med. Commun. 2003; 24: 755-762.
11. Palestro CJ, Tomas MB, Tronco GG. Radionuclide imaging of the parathyroid glands. Sem. Nucl. Med. 2005; 35: 266-276.
12. Kettle AG, O'Doherty MJ. Parathyroid imaging: how good is it and how should it be done? Sem. Nucl. Med. 2006; 36: 206-211.
13. Neumann DR, Esselstyn CB, MacIntyre WJ, Go RT, Obuchowski NA, Chen EQ, Licata AA. Comparison of FDG-PET and sestamibi-SPECT in primary hyperparathyroidism. J. Nucl. Med. 1996; 37: 1809-1815.
14. Melon P, Luxen A, Hamoir E, Meurisse M. Fluorine-18-fluorodeoxyglucose positron emission tomography for preoperative parathyroid imaging in primary hyperparathyroidism. Eur. J. Nucl. Med. 1995; 22: 556-558.
15. Sundin A, Johansson C, Hellman P, Bergstrom M, Ahlstrom H, Jacobson GB, Langstrom B, Rastad J. PET and parathyroid L-[carbon-11] methionine accumulation in hyperparathyroidism. J. Nucl. Med. 1996; 37: 1766-1770.
16. 11C-methionine PET. Eur. J. Nucl. Med. Mol. Imag. 2004; 31: 1405-1412.
17. Pirotte B, Goldman S, Dewitte O, Massager N, Wikler D, Lefranc F, Ben Taib NO, Rorive S, David P, Brotchi J, Levivier M. Integrated positron emission tomography and magnetic resonance imaging-guided resection of brain tumors: a report of 103 consecutive procedures. J. Neurosurg. 2006; 104: 238-253.
18. Perrier ND, Ituarte PH, Morita E, Hamill T, Gielow R, Duh QY, Clark OH. Parathyroid surgery: separating promise from reality. J. Clin. Endocrinol. Metab. 2002; 87: 1024-1029.
19. Lahoutte T, Caveliers V, Franken PR, Bossuyt A, Mertens J, Everaert H. Increased tumor uptake of 3-(123)I-iodo-L-alpha-methyltyrosine after preloading with amino acids: an in vivo animal imaging study. J. Nucl. Med. 2002; 43: 1201-1206.
20. Lindholm P, Leskinen-Kallio S, Kirvela O, Nagren K, Lehikoinen P, Pulkki K, Peltola O, Ruotsalainen U, Teras M, Joensuu H. Head and neck cancer: effect of food ingestion on uptake of C-11 methionine. Radiology 1994; 190: 863-867.
21. Mercier S, Breuille D, Buffiere C, Gimonet J, Papet I, Mirand PP, Obled C. Methionine kinetics are altered in the elderly both in the basal state and after vaccination. Am. J. Clin. Nutr. 2006; 83: 291-298.
22. Lahoutte T, Caveliers V, Camargo SM, Franca R, Ramadan T, Veljkovic E, Mertens J, Bossuyt A, Verrey F. SPECT and PET amino acid tracer influx via system L (h4F2hc-hLAT1) and its transstimulation. J. Nucl. Med. 2004; 45: 1591-1596.
23. 3H]methyl]-L-methionine. J. Nucl. Med. 2000; 41: 1250-1255.
24. Gayed IW, Kim EE, Broussard WF, Evans D, Lee J, Broemeling LD, Ochoa BB, Moxley DM, Erwin WD, Podoloff DA. The value of 99mTc-sestamibi SPECT/CT over conventional SPECT in the evaluation of parathyroid adenomas or hyperplasia. J. Nucl. Med. 2005; 46: 248-252.
25. Krausz Y, Bettman L, Guralnik L, Yosilevsky G, Keidar Z, Bar-Shalom R, Even-Sapir E, Chisin R, Israel O. Technetium-99m-MIBI SPECT/CT in primary hyperparathyroidism. Wld J. Surg. 2006; 30: 76-83.
26. 11C-methionine positron emission tomography. Nucl. Med. Commun. 2005; 26: 133-136.
27. Rubello D, Fanti S, Nanni C, Farsad M, Castellucci P, Boschi S, Franchi R, Mariani G, Fig LM, Gross MD. (11)C-methionine PET/CT in (99m)Tc-sestamibi-negative hyperparathyroidism in patients with renal failure on chronic haemodialysis. Eur. J. Nucl. Med. Mol. Imag. 2006; 33: 453-459.
28. Rubello D, Casara D, Giannini S, Piotto A, De Carlo E, Muzzio PC, Pelizzo MR. Importance of radio-guided minimally invasive parathyroidectomy using hand-held gamma probe and low (99m)Tc-MIBI dose. Technical considerations and long-term clinical results. Q.J. Nucl. Med. 2003; 47: 129-138.
29. Lange-Nolde A, Zajic T, Slawik M, Brink I, Reincke M, Moser E, Hoegerle S. PET with 18F-DOPA in the imaging of parathyroid adenoma in patients with primary hyperparathyroidism. A. pilot study. Nuklearmedizin 2006; 45: 193-196.